ATG2B and B-cell chronic lymphocytic leukemia: ATG2B is a direct target of miR-130a, which inhibits autophagy and promotes cell death and chemosensitivity by downregulating ATG2B expression in chronic lymphocytic leukemia and gastrointestinal stromal tumor (GIST) (24, 25).